comparemela.com

Athira Pharma Inc. (ATHA) Advances Phase 2/3 LIFT-AD Clinical Study of Fosgonimeton in Mild-to-Moderate Alzheimer's Patients

Athira Pharma Inc. (ATHA) Advances Phase 2/3 LIFT-AD Clinical Study of Fosgonimeton in Mild-to-Moderate Alzheimer's Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Seattle ,Washington ,United States ,Mark Litton ,Julie Rathbun Athira Pharma ,Fosgonimeton ,Hans Moebius ,Instagram ,Linkedin ,Twitter ,National Institutes Of Health ,Nasdaq ,Athira Pharma Inc ,Alzheimer Disease Cooperative Study ,Exchange Commission ,Securities Exchange ,Global Statistical Test ,Disease Assessment Scale Cognitive Subscale ,Disease Cooperative Study Activities ,Daily Living ,Chief Medical Officer ,Chief Executive Officer ,National Institute ,National Institutes ,Athira Pharma ,Looking Statements This ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Media Contact ,Rathbun Athira Pharma ,

comparemela.com © 2020. All Rights Reserved.